2024

1. ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study

   Haematologica, Vol. 109, Núm. 3, pp. 867-876

2. Acute pulmonary embolism masking a pulmonary artery sarcoma

   Medicina Clinica

3. Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis

   Antioxidants, Vol. 13, Núm. 1

4. Assessing the Effectiveness of Textual Recommendations in KoopaML: A Comparative Study on Non-Expert Users' ML Pipeline Development

   International Journal on Semantic Web and Information Systems, Vol. 20, Núm. 1

5. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

   JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72

6. CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents (ESAs)

   Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 22, Núm. 25

7. COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS: A SERIES OF 5 CASES

   European Journal of Case Reports in Internal Medicine, Vol. 11, Núm. 1

8. Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study

   Clinical Lymphoma, Myeloma and Leukemia, Vol. 24, Núm. 4, pp. 224-231.e2

9. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

   British Journal of Surgery, Vol. 111, Núm. 3

10. Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

    Advances in Therapy, Vol. 41, Núm. 2, pp. 696-715

11. Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

    Advances in Therapy, Vol. 41, Núm. 4, pp. 1576-1593

12. Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology

    PLoS Computational Biology, Vol. 20, Núm. 2

13. Cuidados continuos en Oncología (I): generalidades

    Oncología clínica (Arán Ediciones), pp. 147-155

14. Cuidados continuos en oncología (II): control de los principales síntomas y del dolor, cuidados en el final de la vida, duelo

    Oncología clínica (Arán Ediciones), pp. 157-173

15. Cuidados continuos en oncología (III): infecciones en el paciente con cáncer, neutropenia febril

    Oncología clínica (Arán Ediciones), pp. 175-188

16. Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets

    Dermatology Research and Practice, Vol. 2024

17. Cáncer de cabeza y cuello

    Oncología clínica (Arán Ediciones), pp. 259-271

18. Cáncer de colon y recto

    Oncología clínica (Arán Ediciones), pp. 303-317

19. Cáncer de mama

    Oncología clínica (Arán Ediciones), pp. 203-226

20. Cáncer de próstata

    Oncología clínica (Arán Ediciones), pp. 347-361